project id: TCGA-OV; case submitter id: TCGA-25-2409; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 6.9; spectrophotometer method: UV Spec; age at index: 71; days to birth: -26267; days to death: 821; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1934; year of death: 2007; age at diagnosis: 26267; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 821.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.5; longest dimension: 1.5; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-25-2409-01A-01; percent necrosis: 1.0; percent normal cells: 1.0; percent stromal cells: 4.0; percent tumor cells: 94.0; percent tumor nuclei: 95.0;